Free Trial

Geron (GERN) Financials

Geron logo
$1.49 +0.04 (+2.76%)
Closing price 04:00 PM Eastern
Extended Trading
$1.51 +0.02 (+1.07%)
As of 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for Geron

Annual Income Statements for Geron

This table shows Geron's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Net Income / (Loss) Attributable to Common Shareholders
-175 -184 -142 -116 -76 -69 -27 -28 -30 0.05 -36
Consolidated Net Income / (Loss)
-175 -184 -142 -116 -76 -69 -27 -28 -30 0.05 -36
Net Income / (Loss) Continuing Operations
-175 -184 -142 -116 -76 -69 -27 -28 -30 0.05 -36
Total Pre-Tax Income
-175 -184 -142 -116 -76 -69 -27 -28 -30 0.05 -36
Total Operating Income
-174 -194 -139 -114 -77 -73 -31 -29 -31 -0.56 -36
Total Gross Profit
76 0.00 0.00 1.39 0.25 0.46 1.07 1.07 6.16 36 1.15
Total Revenue
77 0.00 0.00 1.39 0.25 0.46 1.07 1.07 6.16 36 1.15
Operating Revenue
77 0.00 0.00 1.39 0.25 0.46 1.07 1.07 6.16 36 1.15
Total Cost of Revenue
1.26 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cost of Revenue
1.26 0.00 0.00 - - - - - - - -
Total Operating Expenses
249 194 139 115 77 73 32 30 37 37 37
Selling, General & Admin Expense
146 69 44 30 26 21 19 19 19 18 17
Research & Development Expense
104 125 96 86 51 52 13 11 18 18 21
Total Other Income / (Expense), net
-0.84 9.82 -3.35 -2.11 1.30 3.96 4.06 1.34 1.11 0.61 0.64
Interest Expense
20 8.31 6.88 3.74 0.76 0.00 0.00 - - - -
Interest & Investment Income
20 18 2.53 0.53 1.83 4.22 3.25 1.42 1.19 0.68 0.37
Other Income / (Expense), net
-0.24 -0.02 1.00 1.10 0.23 -0.26 0.81 -0.08 -0.08 -0.07 0.27
Basic Earnings per Share
($0.27) ($0.32) ($0.37) ($0.35) ($0.28) ($0.36) ($0.15) ($0.18) ($0.19) $0.00 ($0.23)
Weighted Average Basic Shares Outstanding
646.03M 570.65M 380.78M 327.63M 271.46M 190.16M 176.50M 159.22M 159.05M 158.04M 153.54M
Diluted Earnings per Share
($0.27) ($0.32) ($0.37) ($0.35) ($0.28) ($0.36) ($0.15) ($0.18) ($0.19) $0.00 ($0.23)
Weighted Average Diluted Shares Outstanding
646.03M 570.65M 380.78M 327.63M 271.46M 190.16M 176.50M 159.22M 159.05M 162.66M 153.54M
Weighted Average Basic & Diluted Shares Outstanding
636.90M 546.06M 508.72M 327.63M 271.46M 190.16M 176.50M 159.22M 159.05M 158.92M 155.10M

Quarterly Income Statements for Geron

This table shows Geron's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Income / (Loss) Attributable to Common Shareholders
-20 -25 -26 -67 -55 -52 -45 -49 -38 -43 -41
Consolidated Net Income / (Loss)
-20 -25 -26 -67 -55 -52 -45 -49 -38 -43 -41
Net Income / (Loss) Continuing Operations
-20 -25 -26 -67 -55 -52 -45 -49 -38 -43 -41
Total Pre-Tax Income
-20 -25 -26 -67 -55 -52 -45 -49 -38 -43 -41
Total Operating Income
-17 -20 -28 -69 -56 -54 -48 -52 -40 -42 -40
Total Gross Profit
38 47 28 0.87 0.00 -0.19 0.16 0.03 0.00 -0.42 0.30
Total Revenue
40 48 28 0.88 0.00 -0.19 0.16 0.03 0.00 -0.42 0.30
Operating Revenue
40 - 28 0.88 - - 0.16 0.03 - - 0.30
Total Cost of Revenue
1.21 0.78 0.46 0.02 0.00 - 0.00 0.00 0.00 - 0.00
Operating Cost of Revenue
1.21 - 0.46 0.02 - - 0.00 0.00 - - -
Total Operating Expenses
55 67 56 70 56 54 48 52 40 42 40
Selling, General & Admin Expense
40 43 36 39 27 21 18 16 13 14 16
Research & Development Expense
15 23 20 31 29 33 29 35 27 28 25
Total Other Income / (Expense), net
-3.13 -5.30 1.77 1.95 0.74 2.32 2.81 2.72 1.97 -0.68 -1.10
Interest Expense
8.20 10 3.05 3.32 3.43 2.32 2.07 2.00 1.92 2.01 1.82
Interest & Investment Income
5.15 5.16 4.88 5.33 4.24 4.60 4.97 4.74 3.85 1.24 0.85
Other Income / (Expense), net
-0.08 -0.05 -0.06 -0.06 -0.06 0.04 -0.09 -0.01 0.04 0.09 -0.14
Basic Earnings per Share
($0.03) ($0.04) ($0.04) ($0.10) ($0.09) ($0.08) ($0.08) ($0.09) ($0.07) ($0.11) ($0.10)
Weighted Average Basic Shares Outstanding
665.91M 646.03M 662.16M 653.90M 603.49M 570.65M 579.51M 547.28M 544.46M 380.78M 405.24M
Diluted Earnings per Share
($0.03) ($0.04) ($0.04) ($0.10) ($0.09) ($0.08) ($0.08) ($0.09) ($0.07) ($0.11) ($0.10)
Weighted Average Diluted Shares Outstanding
665.91M 646.03M 662.16M 653.90M 603.49M 570.65M 579.51M 547.28M 544.46M 380.78M 405.24M
Weighted Average Basic & Diluted Shares Outstanding
636.92M 636.90M 604.50M 602.80M 593.13M 546.06M 543.06M 523.37M 508.77M 508.72M 381.24M

Annual Cash Flow Statements for Geron

This table details how cash moves in and out of Geron's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Net Change in Cash & Equivalents
9.74 14 22 25 -3.63 3.07 -5.76 3.53 -8.44 -22 30
Net Cash From Operating Activities
-219 -168 -127 -96 -67 -44 -21 -21 -18 -24 9.35
Net Cash From Continuing Operating Activities
-219 -168 -127 -96 -67 -44 -21 -21 -18 -24 9.35
Net Income / (Loss) Continuing Operations
-175 -184 -142 -116 -76 -69 -27 -28 -30 0.05 -36
Consolidated Net Income / (Loss)
-175 -184 -142 -116 -76 -69 -27 -28 -30 0.05 -36
Depreciation Expense
0.55 0.44 0.29 0.22 0.16 0.06 0.06 0.08 0.08 0.06 0.05
Amortization Expense
-12 -9.47 0.94 2.89 1.77 -0.82 -0.98 0.27 0.55 2.10 2.89
Non-Cash Adjustments To Reconcile Net Income
35 21 6.88 5.90 6.73 18 7.55 6.76 10 11 7.63
Changes in Operating Assets and Liabilities, net
-67 4.57 6.41 12 0.30 7.10 -0.63 0.26 0.32 -37 34
Net Cash From Investing Activities
-106 -180 62 72 -105 27 -78 23 8.76 0.07 -78
Net Cash From Continuing Investing Activities
-106 -180 62 72 -105 27 -78 23 8.76 0.07 -78
Purchase of Property, Plant & Equipment
-0.68 -0.83 -0.43 -0.21 -0.40 -0.41 -0.02 - -0.06 -0.09 -0.13
Purchase of Investments
-477 -476 -258 -177 -313 -153 -188 -100 -129 -206 -190
Sale and/or Maturity of Investments
372 296 321 248 208 181 111 123 138 207 112
Net Cash From Financing Activities
334 362 87 49 168 19 93 1.11 1.17 2.58 98
Net Cash From Continuing Financing Activities
334 362 87 49 168 19 93 1.11 1.17 2.58 98
Repayment of Debt
-87 0.00 0.00 - - - - - - - -
Issuance of Debt
121 30 0.00 25 24 0.00 0.00 - - - -
Issuance of Common Equity
173 226 72 21 144 19 93 1.11 1.17 2.58 98
Other Financing Activities, net
126 106 15 2.48 0.02 0.00 0.00 - - - -

Quarterly Cash Flow Statements for Geron

This table details how cash moves in and out of Geron's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Change in Cash & Equivalents
4.73 19 -56 -73 120 40 -26 -56 56 -4.26 -15
Net Cash From Operating Activities
-48 -44 -59 -53 -62 -41 -51 -30 -46 -35 -30
Net Cash From Continuing Operating Activities
-48 -44 -59 -53 -62 -41 -51 -30 -46 -35 -30
Net Income / (Loss) Continuing Operations
-20 -25 -26 -67 -55 -52 -45 -49 -38 -43 -41
Consolidated Net Income / (Loss)
-20 -25 -26 -67 -55 -52 -45 -49 -38 -43 -41
Depreciation Expense
0.13 0.14 0.03 0.26 0.11 0.11 0.11 0.12 0.10 0.08 0.08
Amortization Expense
-1.78 -7.23 -1.82 -1.67 -1.40 -2.34 -2.96 -2.84 -1.33 -0.58 0.23
Non-Cash Adjustments To Reconcile Net Income
8.67 10 6.91 13 4.97 6.08 7.64 4.04 3.07 0.93 2.18
Changes in Operating Assets and Liabilities, net
-35 -22 -38 2.67 -11 7.18 -11 18 -10 7.03 8.98
Net Cash From Investing Activities
52 -104 -0.55 -36 34 48 -4.71 -44 -179 19 9.84
Net Cash From Continuing Investing Activities
52 -104 -0.55 -36 34 48 -4.71 -44 -179 19 9.84
Purchase of Property, Plant & Equipment
0.03 0.14 - -0.21 -0.62 -0.06 -0.19 -0.20 -0.37 -0.14 -0.17
Purchase of Investments
-46 -185 -66 -161 -66 -16 -104 -114 -242 -161 -40
Sale and/or Maturity of Investments
99 81 65 125 100 64 99 70 63 180 50
Net Cash From Financing Activities
0.26 166 3.58 17 148 33 29 18 281 12 4.78
Net Cash From Continuing Financing Activities
0.26 166 3.58 17 148 33 29 18 281 12 4.78
Issuance of Common Equity
0.26 5.62 3.57 16 148 3.58 1.04 0.57 221 0.22 1.20
Other Financing Activities, net
0.00 126 0.00 0.37 0.05 - 28 18 60 12 3.64
Effect of Exchange Rate Changes
0.02 - 0.05 -0.02 -0.01 -0.02 0.01 0.00 -0.02 0.01 0.01

Annual Balance Sheets for Geron

This table presents Geron's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Total Assets
594 394 191 226 271 166 185 110 130 149 173
Total Current Assets
491 341 180 187 200 142 166 96 116 116 153
Cash & Equivalents
79 70 57 35 9.93 14 11 16 13 21 43
Restricted Cash
1.86 1.12 0.36 0.36 0.36 0.27 0.27 0.27 0.27 0.27 0.27
Short-Term Investments
328 264 116 149 186 126 153 78 102 93 109
Note & Lease Receivable
2.85 1.66 3.14 1.76 0.72 0.80 1.17 0.44 0.48 1.21 0.96
Accounts Receivable
36 0.00 - - - - - - - - -
Inventories, net
39 0.00 - - - - - - - - -
Prepaid Expenses
5.05 4.88 3.99 1.36 2.50 1.21 1.33 0.58 0.52 0.65 0.74
Plant, Property, & Equipment, net
1.31 1.18 0.79 0.65 0.66 0.41 0.06 0.10 0.18 0.21 0.17
Total Noncurrent Assets
101 52 9.54 38 70 24 19 14 14 33 19
Long-Term Investments
95 43 0.00 29 63 20 19 14 14 33 19
Other Noncurrent Operating Assets
6.96 8.25 9.54 9.53 6.83 3.85 0.59 - - - -
Total Liabilities & Shareholders' Equity
594 394 191 226 271 166 185 110 130 149 173
Total Liabilities
313 146 111 100 60 30 7.55 6.52 7.87 6.63 42
Total Current Liabilities
88 108 77 46 31 28 7.55 6.52 7.87 6.63 42
Short-Term Debt
0.00 47 21 0.00 - - - - - - -
Accounts Payable
8.60 6.16 10 6.69 6.92 1.18 0.98 0.50 0.23 0.16 1.03
Accrued Expenses
36 40 33 30 15 7.53 1.32 0.93 4.80 3.45 1.54
Current Employee Benefit Liabilities
23 14 12 8.10 8.22 4.83 2.64 3.39 2.84 3.03 4.21
Other Current Liabilities
21 0.95 0.93 0.90 0.88 15 2.61 1.70 - - 0.02
Total Noncurrent Liabilities
225 38 34 54 29 2.20 0.00 0.00 0.00 0.00 0.00
Long-Term Debt
118 35 30 50 24 0.00 - - - - -
Other Noncurrent Operating Liabilities
107 3.01 3.67 4.27 4.80 2.20 - - - - -
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
280 248 80 126 211 135 178 104 122 142 131
Total Preferred & Common Equity
280 248 80 126 211 135 178 104 122 142 131
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
280 248 80 126 211 135 178 104 122 142 131
Common Stock
2,052 1,846 1,494 1,398 1,366 1,215 1,189 1,090 1,080 1,071 1,059
Retained Earnings
-1,772 -1,598 -1,414 -1,272 -1,156 -1,080 -1,011 -986 -958 -928 -928
Accumulated Other Comprehensive Income / (Loss)
0.26 0.19 -0.22 -0.17 0.08 0.13 -0.18 -0.21 -0.05 -0.21 -0.08

Quarterly Balance Sheets for Geron

This table presents Geron's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q3 2024 Q2 2024 Q1 2024 Q3 2023 Q2 2023 Q1 2023 Q3 2022
Period end date 3/31/2025 9/30/2024 6/30/2024 3/31/2024 9/30/2023 6/30/2023 3/31/2023 9/30/2022
Total Assets
562 445 449 482 413 415 425 233
Total Current Assets
496 398 373 452 335 377 387 222
Cash & Equivalents
84 60 117 190 31 57 113 61
Restricted Cash
1.87 1.85 1.12 1.12 0.54 0.54 0.37 0.36
Short-Term Investments
313 279 246 253 283 314 268 134
Note & Lease Receivable
2.82 2.08 2.25 1.63 15 1.19 1.60 22
Accounts Receivable
31 28 0.87 - - - - -
Inventories, net
56 20 0.77 - - - - -
Prepaid Expenses
6.82 6.06 5.55 5.71 6.27 4.18 4.32 4.70
Plant, Property, & Equipment, net
1.15 1.60 1.63 1.68 1.23 1.15 1.07 0.73
Total Noncurrent Assets
66 45 74 29 77 37 37 9.80
Long-Term Investments
59 37 67 21 68 28 28 0.00
Other Noncurrent Operating Assets
6.74 7.99 7.96 8.10 8.88 8.59 8.69 9.80
Total Liabilities & Shareholders' Equity
562 445 449 482 413 415 425 233
Total Liabilities
294 153 143 137 122 117 99 124
Total Current Liabilities
63 138 104 123 89 73 44 83
Short-Term Debt
0.00 72 47 72 22 11 0.00 13
Accounts Payable
8.03 14 5.62 9.99 14 7.67 3.38 8.18
Accrued Expenses
29 36 39 34 42 45 35 53
Current Employee Benefit Liabilities
9.60 15 11 6.79 11 8.23 4.91 7.64
Other Current Liabilities
17 0.97 0.96 0.96 0.94 0.79 0.93 0.92
Total Noncurrent Liabilities
231 15 39 14 33 44 55 42
Long-Term Debt
119 12 37 11 30 41 51 38
Other Noncurrent Operating Liabilities
112 2.46 2.65 2.83 3.18 3.50 3.51 3.83
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
268 292 307 345 291 298 326 108
Total Preferred & Common Equity
268 292 307 345 291 298 326 108
Total Common Equity
268 292 307 345 291 298 326 108
Common Stock
2,060 2,038 2,028 1,998 1,837 1,800 1,778 1,480
Retained Earnings
-1,792 -1,747 -1,721 -1,653 -1,546 -1,501 -1,452 -1,371
Accumulated Other Comprehensive Income / (Loss)
0.30 1.02 -0.54 -0.27 -0.95 -0.95 -0.16 -0.62

Annual Metrics And Ratios for Geron

This table displays calculated financial ratios and metrics derived from Geron's official financial filings.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Growth Metrics
- - - - - - - - - - -
Revenue Growth
0.00% 0.00% -100.00% 450.59% -45.00% -56.85% 0.09% -82.72% -83.06% 3,054.47% -10.13%
EBITDA Growth
8.60% -48.91% -24.15% -46.88% -1.67% -135.76% -7.60% 3.70% -2,076.10% 104.60% 11.07%
EBIT Growth
10.31% -41.02% -21.83% -47.22% -5.38% -140.42% -3.19% 4.55% -4,769.89% 98.25% 8.36%
NOPAT Growth
10.42% -39.98% -21.54% -48.22% -6.08% -133.34% -6.21% 4.54% -3,737.60% 97.80% 6.79%
Net Income Growth
5.19% -29.76% -22.21% -53.55% -10.31% -153.72% 3.22% 5.49% -64,310.87% 100.13% 7.06%
EPS Growth
15.63% 13.51% -5.71% -25.00% 22.22% -140.00% 16.67% 5.26% 0.00% 100.00% 23.33%
Operating Cash Flow Growth
-30.33% -31.69% -33.30% -43.37% -52.07% -108.62% -2.20% -11.91% 24.08% -358.78% 125.49%
Free Cash Flow Firm Growth
49.28% -41.49% -33.91% -29.21% -70.24% -36.62% -4.48% -12.56% 46.15% -535.48% 126.03%
Invested Capital Growth
-115.99% -14.93% -14.97% -45.75% -3.92% -446.65% 18.36% 19.28% -46.20% 88.54% -537.61%
Revenue Q/Q Growth
165.86% 100.00% -100.00% 373.81% -32.35% -30.72% 20.86% 10.02% -2.00% 0.12% -3.92%
EBITDA Q/Q Growth
13.63% -7.47% -9.79% -7.53% 9.14% -40.57% -3.65% 3.38% -1.76% 19.64% 1.72%
EBIT Q/Q Growth
16.41% -6.82% -8.59% -7.30% 8.06% -42.35% -1.94% 3.29% -0.45% 37.77% 0.96%
NOPAT Q/Q Growth
16.46% -6.79% -8.60% -7.26% 8.06% -39.20% -6.16% 3.29% -0.45% 13.76% 0.72%
Net Income Q/Q Growth
13.23% -5.34% -8.09% -7.63% 6.53% -46.54% 0.48% 3.63% -0.05% 110.62% 0.93%
EPS Q/Q Growth
12.90% 8.57% -5.71% -2.94% 20.00% -44.00% 6.25% 5.26% -5.56% 0.00% 11.54%
Operating Cash Flow Q/Q Growth
-1.39% -3.55% -11.38% -11.11% -3.49% -20.17% 6.15% -22.57% 20.20% -353.84% 136.06%
Free Cash Flow Firm Q/Q Growth
63.94% -4.46% -10.65% -10.57% -9.25% -0.67% 3.81% -23.50% 20.51% -1,639.75% 132.41%
Invested Capital Q/Q Growth
-3,594.54% -22.47% -15.83% -23.18% -46.95% -249.50% -240.05% -21.33% -643.83% -18.10% -654.91%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
98.37% 0.00% 0.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
EBITDA Margin
-240.98% 0.00% 0.00% -7,882.20% -29,546.64% -15,984.13% -2,925.61% -2,721.41% -488.41% 4.19% -2,871.38%
Operating Margin
-225.64% 0.00% 0.00% -8,183.70% -30,400.40% -15,761.96% -2,914.92% -2,746.95% -497.34% -1.54% -3,149.35%
EBIT Margin
-225.95% 0.00% 0.00% -8,104.74% -30,310.28% -15,819.35% -2,839.40% -2,754.18% -498.69% -1.73% -3,126.02%
Profit (Net Income) Margin
-226.73% 0.00% 0.00% -8,335.39% -29,888.14% -14,901.74% -2,534.43% -2,621.22% -479.34% 0.13% -3,093.67%
Tax Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent
100.35% 94.93% 103.16% 102.85% 98.61% 94.20% 89.26% 95.17% 96.12% -7.29% 98.97%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)
-66.09% -112.29% -137.49% -68.84% -43.70% -43.82% -19.19% -24.69% -22.33% 0.03% -37.45%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)
-35.22% 0.00% 0.00% -45.45% -35.16% -41.49% -20.48% -24.39% -22.03% -0.39% -30.05%
Return on Assets (ROA)
-35.34% 0.00% 0.00% -46.75% -34.67% -39.08% -18.28% -23.21% -21.17% 0.03% -29.74%
Return on Common Equity (ROCE)
-66.09% -112.29% -137.49% -68.84% -43.70% -43.82% -19.19% -24.69% -22.33% 0.03% -37.45%
Return on Equity Simple (ROE_SIMPLE)
-62.28% -74.26% -177.38% -91.85% -35.85% -50.72% -15.20% -26.89% -24.14% 0.03% -27.29%
Net Operating Profit after Tax (NOPAT)
-122 -136 -97 -80 -54 -51 -22 -20 -21 -0.56 -25
NOPAT Margin
-157.95% 0.00% 0.00% -5,728.59% -21,280.28% -11,033.37% -2,040.44% -1,922.86% -348.14% -1.54% -2,204.54%
Net Nonoperating Expense Percent (NNEP)
-15.56% -23.14% -31.54% -18.21% -11.02% -10.42% -3.62% -6.24% -5.86% 0.38% -8.66%
Return On Investment Capital (ROIC_SIMPLE)
-30.49% -41.15% -73.95% -45.28% -22.91% -37.55% -12.24% -19.73% -17.53% -0.39% -19.45%
Cost of Revenue to Revenue
1.63% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue
189.28% 0.00% 0.00% 2,129.58% 10,149.41% 4,541.96% 1,754.88% 1,810.99% 304.46% 48.92% 1,453.43%
R&D to Revenue
134.74% 0.00% 0.00% 6,154.13% 20,350.99% 11,320.00% 1,260.04% 1,035.96% 292.88% 49.03% 1,795.92%
Operating Expenses to Revenue
324.01% 0.00% 0.00% 8,283.70% 30,500.40% 15,861.96% 3,014.92% 2,846.95% 597.34% 101.54% 3,249.35%
Earnings before Interest and Taxes (EBIT)
-174 -194 -138 -113 -77 -73 -30 -29 -31 -0.63 -36
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-186 -203 -136 -110 -75 -74 -31 -29 -30 1.52 -33
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
7.63 4.62 11.53 3.11 2.34 2.01 1.05 2.76 2.69 5.39 3.91
Price to Tangible Book Value (P/TBV)
7.63 4.62 11.53 3.11 2.34 2.01 1.05 2.76 2.69 5.39 3.91
Price to Revenue (P/Rev)
27.79 0.00 0.00 281.97 1,951.19 590.65 174.81 269.12 53.46 21.06 443.14
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 16,647.70 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.01% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
22.80 0.00 0.00 165.02 1,018.45 244.46 3.95 166.59 32.52 17.02 295.14
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 406.50 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 36.40
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 41.27
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.42 0.33 0.64 0.39 0.11 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.42 0.14 0.38 0.39 0.11 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-1.29 -1.28 -1.38 -1.18 -1.14 -1.09 -1.03 -1.05 -1.04 -1.16 -1.24
Leverage Ratio
1.87 1.78 2.02 1.47 1.26 1.12 1.05 1.06 1.05 1.18 1.26
Compound Leverage Factor
1.88 1.69 2.08 1.51 1.24 1.06 0.94 1.01 1.01 -0.09 1.25
Debt to Total Capital
29.71% 24.84% 39.01% 28.27% 10.23% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 14.21% 15.97% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
29.71% 10.63% 23.04% 28.27% 10.23% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
70.29% 75.16% 61.00% 71.73% 89.77% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA
-0.64 -0.40 -0.38 -0.45 -0.32 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
2.07 1.46 0.89 1.48 3.16 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
-0.64 -0.17 -0.22 -0.45 -0.32 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
-0.97 -0.60 -0.53 -0.62 -0.45 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
3.16 2.18 1.26 2.04 4.38 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
-0.97 -0.26 -0.31 -0.62 -0.45 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
-0.11 -1.89 -7.11 -6.40 -1.21 -4.39 7.66 13.99 15.09 61.64 -0.11
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
5.56 3.16 2.35 4.11 6.46 5.03 21.99 14.73 14.76 17.47 3.67
Quick Ratio
5.04 3.10 2.29 4.07 6.37 4.98 21.78 14.60 14.66 17.33 3.65
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-66 -129 -92 -68 -53 -31 -23 -22 -19 -36 8.25
Operating Cash Flow to CapEx
-32,149.71% -20,210.00% -29,554.29% 0.00% -107,503.23% -10,612.35% -131,306.25% 0.00% -44,802.44% -26,884.44% 7,137.40%
Free Cash Flow to Firm to Interest Expense
-3.25 -15.58 -13.30 -18.27 -69.60 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
-10.82 -20.18 -18.51 -25.55 -87.70 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
-10.85 -20.28 -18.57 -25.18 -87.78 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.16 0.00 0.00 0.01 0.00 0.00 0.01 0.01 0.04 0.23 0.01
Accounts Receivable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
61.92 0.00 0.00 2.13 0.47 1.97 13.24 7.47 31.60 191.43 8.70
Accounts Payable Turnover
0.17 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
2,144.08 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)
-2,144.08 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
-104 -48 -42 -36 -25 -24 -4.41 -5.40 -6.69 -4.57 -40
Invested Capital Turnover
-1.01 0.00 0.00 -0.05 -0.01 -0.03 -0.22 -0.18 -1.09 -1.63 -0.05
Increase / (Decrease) in Invested Capital
-56 -6.26 -5.46 -11 -0.95 -20 0.99 1.29 -2.11 35 -34
Enterprise Value (EV)
1,755 850 801 230 258 112 4.21 177 200 619 340
Market Capitalization
2,140 1,146 923 393 494 272 186 287 329 766 511
Book Value per Share
$0.46 $0.46 $0.21 $0.39 $0.68 $0.68 $0.95 $0.65 $0.77 $0.90 $0.83
Tangible Book Value per Share
$0.46 $0.46 $0.21 $0.39 $0.68 $0.68 $0.95 $0.65 $0.77 $0.90 $0.83
Total Capital
399 330 131 176 235 135 178 104 122 142 131
Total Debt
118 82 51 50 24 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
118 35 30 50 24 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
-384 -296 -122 -163 -236 -159 -182 -109 -129 -147 -171
Capital Expenditures (CapEx)
0.68 0.83 0.43 -1.39 0.06 0.41 0.02 0.00 0.04 0.09 0.13
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-5.73 -55 -49 -42 -28 -26 -5.05 -5.50 -6.87 -4.78 -40
Debt-free Net Working Capital (DFNWC)
403 280 124 142 169 113 159 89 108 109 112
Net Working Capital (NWC)
403 233 104 142 169 113 159 89 108 109 112
Net Nonoperating Expense (NNE)
53 48 45 36 22 18 5.27 7.44 8.08 -0.61 10
Net Nonoperating Obligations (NNO)
-384 -296 -122 -163 -236 -159 -182 -109 -129 -147 -171
Total Depreciation and Amortization (D&A)
-12 -9.03 1.23 3.10 1.93 -0.76 -0.92 0.35 0.63 2.15 2.94
Debt-free, Cash-free Net Working Capital to Revenue
-7.44% 0.00% 0.00% -3,043.86% -10,956.92% -5,684.57% -473.83% -516.43% -111.49% -13.15% -3,477.88%
Debt-free Net Working Capital to Revenue
523.02% 0.00% 0.00% 10,171.21% 66,765.61% 24,662.17% 14,869.32% 8,399.44% 1,756.62% 300.40% 9,679.71%
Net Working Capital to Revenue
523.02% 0.00% 0.00% 10,171.21% 66,765.61% 24,662.17% 14,869.32% 8,399.44% 1,756.62% 300.40% 9,679.71%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.27) ($0.32) ($0.37) ($0.35) ($0.28) ($0.36) ($0.15) ($0.18) ($0.19) $0.00 ($0.23)
Adjusted Weighted Average Basic Shares Outstanding
646.03M 570.65M 380.78M 323.73M 318.53M 200.34M 186.39M 159.22M 159.05M 158.04M 157.70M
Adjusted Diluted Earnings per Share
($0.27) ($0.32) ($0.37) ($0.35) ($0.28) ($0.36) ($0.15) ($0.18) ($0.19) $0.00 ($0.23)
Adjusted Weighted Average Diluted Shares Outstanding
646.03M 570.65M 380.78M 323.73M 318.53M 200.34M 186.39M 159.22M 159.05M 162.66M 157.70M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 ($0.35) ($0.28) ($0.36) ($0.15) $0.00 $0.00 $0.00 ($0.23)
Adjusted Weighted Average Basic & Diluted Shares Outstanding
636.90M 546.06M 508.72M 327.63M 271.46M 190.16M 176.50M 160.65M 159.16M 158.92M 153.54M
Normalized Net Operating Profit after Tax (NOPAT)
-122 -136 -97 -80 -54 -51 -22 -20 -21 0.52 -25
Normalized NOPAT Margin
-157.95% 0.00% 0.00% -5,728.59% -21,280.28% -11,033.37% -2,040.44% -1,922.86% -348.14% 1.44% -2,204.54%
Pre Tax Income Margin
-226.73% 0.00% 0.00% -8,335.39% -29,888.14% -14,901.74% -2,534.43% -2,621.22% -479.34% 0.13% -3,093.67%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
-8.61 -23.34 -19.99 -30.19 -100.90 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
-6.02 -16.33 -14.09 -21.34 -70.84 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
-8.64 -23.44 -20.05 -29.82 -100.98 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
-6.05 -16.43 -14.16 -20.97 -70.92 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Geron

This table displays calculated financial ratios and metrics derived from Geron's official financial filings.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Growth Metrics
- - - - - - - - - - -
Revenue Growth
12,927.30% 24,888.08% 17,138.41% 2,941.38% 0.00% 54.05% -44.78% 0.00% -100.00% -136.55% 0.00%
EBITDA Growth
67.93% 51.86% 40.53% -29.49% -39.24% -33.30% -27.10% -108.80% -47.52% -40.25% -59.43%
EBIT Growth
70.13% 62.95% 40.72% -33.55% -40.30% -29.58% -19.00% -93.41% -39.41% -35.10% -55.67%
NOPAT Growth
70.24% 63.07% 40.74% -33.46% -40.01% -29.41% -19.18% -85.70% -39.82% -35.40% -55.60%
Net Income Growth
64.19% 51.22% 40.97% -36.88% -45.30% -21.90% -9.14% -75.08% -26.66% -33.16% -53.77%
EPS Growth
66.67% 50.00% 50.00% -11.11% -28.57% 27.27% 20.00% -28.57% 22.22% -22.22% -25.00%
Operating Cash Flow Growth
22.93% -7.35% -15.94% -80.66% -34.27% -16.36% -71.86% -3.35% -36.47% -58.70% -29.52%
Free Cash Flow Firm Growth
163.90% 232.00% -86.58% -335.14% -26.60% -32.79% -41.24% 35.76% -194.06% -133.59% -296.70%
Invested Capital Growth
-89.01% -115.99% 92.84% 19.74% -17.59% -14.93% -8.70% -84.38% -4.75% -14.97% -22.27%
Revenue Q/Q Growth
-17.22% 69.22% 3,105.33% 0.00% 100.00% -217.68% 465.52% 0.00% 100.00% -241.41% 0.00%
EBITDA Q/Q Growth
32.19% 9.57% 57.54% -23.17% -1.79% -11.71% 7.54% -32.43% 2.55% -6.52% -51.89%
EBIT Q/Q Growth
16.47% 28.93% 59.25% -23.49% -3.59% -13.72% 8.19% -29.73% 4.33% -4.44% -49.21%
NOPAT Q/Q Growth
16.69% 28.94% 59.31% -23.51% -3.40% -14.02% 8.35% -29.58% 4.43% -5.01% -42.79%
Net Income Q/Q Growth
21.76% 4.14% 60.75% -21.65% -6.57% -16.00% 8.98% -29.13% 10.59% -3.86% -46.00%
EPS Q/Q Growth
25.00% 0.00% 60.00% -11.11% -12.50% 0.00% 11.11% -28.57% 36.36% -10.00% -42.86%
Operating Cash Flow Q/Q Growth
-9.18% 25.44% -10.22% 14.10% -52.07% 19.48% -71.75% 36.16% -31.79% -18.93% -3.28%
Free Cash Flow Firm Q/Q Growth
-48.58% 174.41% 3.63% -73.32% -6.21% -5.17% -124.76% 49.57% -11.40% -11.87% -2.22%
Invested Capital Q/Q Growth
32.24% -3,594.54% 92.99% -7.75% 22.57% -22.47% 21.45% -57.86% 24.32% -15.83% -33.24%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
96.95% 98.36% 98.39% 98.07% 0.00% 0.00% 100.00% 100.00% 0.00% 0.00% 100.00%
EBITDA Margin
-46.55% -56.83% -106.34% -8,027.55% 0.00% 0.00% -30,826.22% -188,544.83% 0.00% 0.00% -13,392.26%
Operating Margin
-42.18% -41.91% -99.80% -7,860.88% 0.00% 0.00% -29,031.71% -179,141.38% 0.00% 0.00% -13,450.51%
EBIT Margin
-42.39% -42.01% -100.02% -7,868.03% 0.00% 0.00% -29,087.80% -179,179.31% 0.00% 0.00% -13,496.97%
Profit (Net Income) Margin
-50.08% -52.99% -93.55% -7,639.80% 0.00% 0.00% -27,320.12% -169,748.28% 0.00% 0.00% -13,821.89%
Tax Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent
118.16% 126.14% 93.53% 97.10% 98.57% 95.81% 93.92% 94.74% 95.18% 101.84% 102.41%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)
-45.35% -66.09% -69.03% -72.56% -60.04% -112.29% -87.66% -77.66% -70.80% -137.49% -101.09%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)
-9.44% -6.55% -6.75% -15.52% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -91.73%
Return on Assets (ROA)
-11.15% -8.26% -6.32% -15.07% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -93.94%
Return on Common Equity (ROCE)
-45.35% -66.09% -69.03% -72.56% -60.04% -112.29% -87.66% -77.66% -70.80% -137.49% -101.09%
Return on Equity Simple (ROE_SIMPLE)
-51.83% 0.00% -68.83% -71.59% -58.40% 0.00% -60.14% -57.31% -45.98% 0.00% -121.37%
Net Operating Profit after Tax (NOPAT)
-12 -14 -20 -49 -39 -38 -33 -36 -28 -29 -28
NOPAT Margin
-29.53% -29.34% -69.86% -5,502.62% 0.00% 0.00% -20,322.20% -125,398.97% 0.00% 0.00% -9,415.35%
Net Nonoperating Expense Percent (NNEP)
-2.26% -3.33% -2.14% -5.42% -4.35% -6.68% -4.84% -4.97% -4.14% -9.32% -8.04%
Return On Investment Capital (ROIC_SIMPLE)
-3.02% -3.52% -5.25% -12.44% -9.19% -11.52% -9.73% -10.39% -7.44% -22.39% -17.59%
Cost of Revenue to Revenue
3.05% 1.64% 1.61% 1.93% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue
101.06% 90.66% 126.90% 4,469.27% 0.00% 0.00% 11,189.02% 56,862.07% 0.00% 0.00% 5,266.67%
R&D to Revenue
38.07% 48.98% 71.29% 3,489.68% 0.00% 0.00% 17,942.68% 122,379.31% 0.00% 0.00% 8,283.84%
Operating Expenses to Revenue
139.13% 139.64% 198.19% 7,958.96% 0.00% 0.00% 29,131.71% 179,241.38% 0.00% 0.00% 13,550.51%
Earnings before Interest and Taxes (EBIT)
-17 -20 -28 -69 -56 -54 -48 -52 -40 -42 -40
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-18 -27 -30 -71 -57 -56 -51 -55 -41 -42 -40
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
3.78 7.63 9.36 8.20 5.23 4.62 3.82 5.47 3.39 11.53 8.17
Price to Tangible Book Value (P/TBV)
3.78 7.63 9.36 8.20 5.23 4.62 3.82 5.47 3.39 11.53 8.17
Price to Revenue (P/Rev)
8.71 27.79 94.50 2,948.28 0.00 0.00 0.00 0.00 0.00 0.00 563.48
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
5.79 22.80 84.31 2,541.57 0.00 0.00 0.00 0.00 0.00 0.00 471.45
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.44 0.42 0.29 0.27 0.24 0.33 0.18 0.17 0.16 0.64 0.47
Long-Term Debt to Equity
0.44 0.42 0.04 0.12 0.03 0.14 0.10 0.14 0.16 0.38 0.35
Financial Leverage
-1.18 -1.29 -1.07 -1.15 -1.10 -1.28 -1.19 -1.18 -1.15 -1.38 -1.25
Leverage Ratio
1.70 1.87 1.47 1.43 1.35 1.78 1.62 1.48 1.47 2.02 1.78
Compound Leverage Factor
2.01 2.36 1.38 1.39 1.33 1.71 1.52 1.41 1.40 2.06 1.82
Debt to Total Capital
30.68% 29.71% 22.29% 21.39% 19.35% 24.84% 15.15% 14.75% 13.62% 39.01% 31.94%
Short-Term Debt to Total Capital
0.00% 0.00% 19.03% 12.03% 16.73% 14.21% 6.44% 3.10% 0.00% 15.97% 8.15%
Long-Term Debt to Total Capital
30.68% 29.71% 3.26% 9.36% 2.62% 10.63% 8.71% 11.66% 13.62% 23.04% 23.78%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
69.32% 70.29% 77.71% 78.61% 80.65% 75.16% 84.85% 85.25% 86.38% 61.00% 68.06%
Debt to EBITDA
-0.81 -0.64 -0.39 -0.35 -0.38 -0.40 -0.27 -0.29 -0.34 -0.38 -0.41
Net Debt to EBITDA
2.31 2.07 1.37 1.47 1.74 1.46 1.75 1.96 2.39 0.89 1.16
Long-Term Debt to EBITDA
-0.81 -0.64 -0.06 -0.16 -0.05 -0.17 -0.16 -0.23 -0.34 -0.22 -0.30
Debt to NOPAT
-1.26 -0.97 -0.58 -0.52 -0.56 -0.60 -0.41 -0.42 -0.49 -0.53 -0.57
Net Debt to NOPAT
3.60 3.16 2.03 2.18 2.60 2.18 2.60 2.86 3.41 1.26 1.62
Long-Term Debt to NOPAT
-1.26 -0.97 -0.08 -0.23 -0.08 -0.26 -0.23 -0.34 -0.49 -0.31 -0.42
Altman Z-Score
-1.36 0.75 5.82 5.43 3.51 -0.72 0.53 3.79 2.58 -5.45 -3.83
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
7.87 5.56 2.89 3.61 3.67 3.16 3.75 5.20 8.81 2.35 2.68
Quick Ratio
6.84 5.04 2.68 3.53 3.61 3.10 3.67 5.13 8.71 2.29 2.62
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
22 42 -56 -58 -34 -32 -30 -13 -27 -24 -21
Operating Cash Flow to CapEx
0.00% 0.00% 0.00% -25,960.19% -10,122.44% -63,965.63% -26,478.65% -14,653.96% -12,463.71% -25,129.29% -17,299.42%
Free Cash Flow to Firm to Interest Expense
2.63 4.02 -18.48 -17.60 -9.82 -13.67 -14.61 -6.70 -13.85 -11.92 -11.76
Operating Cash Flow to Interest Expense
-5.85 -4.22 -19.35 -16.11 -18.13 -17.64 -24.61 -14.78 -24.12 -17.55 -16.28
Operating Cash Flow Less CapEx to Interest Expense
-5.85 -4.21 -19.35 -16.17 -18.31 -17.67 -24.70 -14.88 -24.32 -17.62 -16.37
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.22 0.16 0.07 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01
Accounts Receivable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
82.24 61.92 20.50 0.62 0.00 0.00 0.00 0.00 0.00 0.00 2.34
Accounts Payable Turnover
0.27 0.17 0.03 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
1,336.06 2,144.08 10,578.83 142,704.26 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)
-1,336.06 -2,144.08 -10,578.83 -142,704.26 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
-71 -104 -2.82 -40 -37 -48 -39 -50 -32 -42 -36
Invested Capital Turnover
-2.16 -1.01 -1.37 -0.02 0.00 0.00 0.00 0.00 0.00 0.00 -0.05
Increase / (Decrease) in Invested Capital
-33 -56 37 9.89 -5.59 -6.26 -3.15 -23 -1.44 -5.46 -6.60
Enterprise Value (EV)
674 1,755 2,442 2,168 1,420 850 780 1,285 746 801 740
Market Capitalization
1,013 2,140 2,737 2,515 1,802 1,146 1,110 1,633 1,104 923 884
Book Value per Share
$0.42 $0.46 $0.48 $0.52 $0.63 $0.46 $0.56 $0.59 $0.64 $0.21 $0.29
Tangible Book Value per Share
$0.42 $0.46 $0.48 $0.52 $0.63 $0.46 $0.56 $0.59 $0.64 $0.21 $0.29
Total Capital
387 399 376 390 428 330 343 350 377 131 159
Total Debt
119 118 84 83 83 82 52 52 51 51 51
Total Long-Term Debt
119 118 12 37 11 35 30 41 51 30 38
Net Debt
-339 -384 -295 -347 -382 -296 -330 -349 -358 -122 -144
Capital Expenditures (CapEx)
-0.03 -0.14 0.00 0.21 0.62 0.06 0.19 0.20 0.37 0.14 0.17
Debt-free, Cash-free Net Working Capital (DFCFNWC)
34 -5.73 -9.94 -47 -44 -55 -46 -56 -38 -49 -43
Debt-free Net Working Capital (DFNWC)
433 403 332 317 400 280 268 316 343 124 152
Net Working Capital (NWC)
433 403 260 270 328 233 246 305 343 104 139
Net Nonoperating Expense (NNE)
8.14 11 6.70 19 16 14 11 13 10 13 13
Net Nonoperating Obligations (NNO)
-339 -384 -295 -347 -382 -296 -330 -349 -358 -122 -144
Total Depreciation and Amortization (D&A)
-1.65 -7.09 -1.79 -1.41 -1.29 -2.23 -2.85 -2.72 -1.23 -0.50 0.31
Debt-free, Cash-free Net Working Capital to Revenue
29.23% -7.44% -34.33% -5,530.13% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -2,736.20%
Debt-free Net Working Capital to Revenue
372.11% 523.02% 1,145.32% 37,126.03% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 9,701.72%
Net Working Capital to Revenue
372.11% 523.02% 898.22% 31,625.79% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 8,875.78%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.03) ($0.04) ($0.04) ($0.10) ($0.09) ($0.08) ($0.08) ($0.09) ($0.07) ($0.11) ($0.10)
Adjusted Weighted Average Basic Shares Outstanding
665.91M 646.03M 662.16M 653.90M 603.49M 570.65M 579.51M 547.28M 544.46M 380.78M 405.24M
Adjusted Diluted Earnings per Share
($0.03) ($0.04) ($0.04) ($0.10) ($0.09) ($0.08) ($0.08) ($0.09) ($0.07) ($0.11) ($0.10)
Adjusted Weighted Average Diluted Shares Outstanding
665.91M 646.03M 662.16M 653.90M 603.49M 570.65M 579.51M 547.28M 544.46M 380.78M 405.24M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
636.92M 636.90M 604.50M 602.80M 593.13M 546.06M 543.06M 523.37M 508.77M 508.72M 381.24M
Normalized Net Operating Profit after Tax (NOPAT)
-12 -14 -20 -49 -39 -38 -33 -36 -28 -29 -28
Normalized NOPAT Margin
-29.53% -29.34% -69.86% -5,502.62% 0.00% 0.00% -20,322.20% -125,398.97% 0.00% 0.00% -9,415.35%
Pre Tax Income Margin
-50.08% -52.99% -93.55% -7,639.80% 0.00% 0.00% -27,320.12% -169,748.28% 0.00% 0.00% -13,821.89%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
-2.05 -1.93 -9.28 -20.91 -16.37 -23.37 -23.09 -25.94 -20.84 -20.88 -22.06
NOPAT to Interest Expense
-1.43 -1.35 -6.48 -14.62 -11.45 -16.37 -16.13 -18.16 -14.60 -14.65 -15.39
EBIT Less CapEx to Interest Expense
-2.04 -1.92 -9.28 -20.97 -16.55 -23.40 -23.18 -26.04 -21.03 -20.95 -22.16
NOPAT Less CapEx to Interest Expense
-1.42 -1.33 -6.48 -14.68 -11.63 -16.40 -16.22 -18.26 -14.80 -14.72 -15.48
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Frequently Asked Questions About Geron's Financials

When does Geron's fiscal year end?

According to the most recent income statement we have on file, Geron's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Geron's net income changed over the last 10 years?

Geron's net income appears to be on an upward trend, with a most recent value of -$174.57 million in 2024, rising from -$35.67 million in 2014. The previous period was -$184.13 million in 2023. See Geron's forecast for analyst expectations on what’s next for the company.

What is Geron's operating income?
Geron's total operating income in 2024 was -$173.73 million, based on the following breakdown:
  • Total Gross Profit: $75.74 million
  • Total Operating Expenses: $249.47 million
How has Geron revenue changed over the last 10 years?

Over the last 10 years, Geron's total revenue changed from $1.15 million in 2014 to $76.99 million in 2024, a change of 6,577.7%.

How much debt does Geron have?

Geron's total liabilities were at $313.46 million at the end of 2024, a 114.5% increase from 2023, and a 649.9% increase since 2014.

How much cash does Geron have?

In the past 10 years, Geron's cash and equivalents has ranged from $9.93 million in 2020 to $79.02 million in 2024, and is currently $79.02 million as of their latest financial filing in 2024.

How has Geron's book value per share changed over the last 10 years?

Over the last 10 years, Geron's book value per share changed from 0.83 in 2014 to 0.46 in 2024, a change of -44.2%.



This page (NASDAQ:GERN) was last updated on 5/27/2025 by MarketBeat.com Staff
From Our Partners